Save 10% off on your first order with coupon code: PANDA10
Pandameds.Com Editorial Team
The Pandameds.Com Editorial Team is dedicated to delivering accurate, transparent and trustworthy health information to help U.S. customers access safe, affordable weight loss medications from Canada. Our team of experienced medical writers, pharmacists and industry professionals ensures every article and product page is thoroughly fact checked, clearly written & updated to reflect the latest clinical guidance.
Each piece of content undergoes a stringent editorial process referencing trusted medical sources such as FDA, Health Canada, PubMed and Mayo Clinic. While we do not provide individual medical advice, our mission is to empower readers with reliable knowledge about medications like Ozempic, Saxenda, Mounjaro, Zepbound, Wegovy and Rybelsus, focused exclusively on their role in medical weight management.
Pandameds.Com helps our readers make informed decisions about their health maintaining a transparent editorial policy and working with certified reviewers
Recent Blog Post
Saxenda Dosage Guide: 0.6mg Start to 3mg Max (5-Week Titration Schedule)
Saxenda dosing starts at 0.6 mg once daily and is gradually increased by 0.6 mg every week until reaching the maintenance dose of 3.0 mg daily-this FDA-approved titration schedule takes approximately 5 weeks to complete. The active ingredient in Saxenda is liraglutide, a GLP-1 receptor agonist manufactured by Novo Nordisk for chronic weight management in [...]
Trulicity vs Zepbound: 4-7% vs 21% Loss – Dual GIP/GLP-1 vs GLP-1
Zepbound delivers dramatically superior weight loss results: participants in clinical trials lost an average of 21% body weight (approximately 48 lbs at the highest dose) compared to Trulicity's modest 4-7% weight loss (7-10 lbs). This substantial difference stems from their fundamentally different mechanisms-Zepbound is a dual GIP and GLP-1 receptor agonist, while Trulicity operates solely [...]
Contrave vs Zepbound 2026: 22.5% vs 8.1% Weight Loss – Pill vs Dual Hormone Injection
Zepbound (tirzepatide) produces approximately 22.5% average total body weight loss at the maximum 15 mg dose over 72 weeks, according to the SURMOUNT-1 clinical trial published in the New England Journal of Medicine. Contrave (naltrexone/bupropion) shows an average of 8.1% total body weight loss at the maximum daily dose over 56 weeks, as documented in [...]
Does Zepbound Cause Depression? No Direct Link + Mood Monitoring Guide
Zepbound (tirzepatide) does not directly cause depression according to clinical evidence. The FDA's comprehensive review of over 107,000 patients found no increased risk of suicidal ideation or behavior (SI/B) associated with GLP-1 receptor agonist medications, including tirzepatide. In January 2026, the FDA requested manufacturers remove the suicide and depression warnings from Zepbound's label based on [...]
Does Zepbound Make You Tired? 10% Fatigue Rate + Complete Recovery Protocol
Zepbound (tirzepatide) can cause fatigue as a side effect, and tiredness is one of the more commonly reported experiences among users. According to FDA prescribing information, fatigue (which includes feelings of weakness, lethargy, and malaise) was reported by 5% of people taking 5 mg, 6% of those on 10 mg, and 7% of those taking [...]
Zepbound Hair Loss: 5% Rate from Rapid Weight Loss Stress – Telogen Effluvium Guide
Yes, Zepbound can cause hair loss, but it affects only about 5% of patients according to FDA clinical trial data. The hair loss associated with Zepbound is not permanent follicle damage-it's a temporary condition called telogen effluvium triggered by rapid weight loss and potential nutritional deficiencies. Women appear to be more affected (7.1%) compared to [...]
Zepbound Diarrhea: 23% Rate + Management Timeline
Zepbound diarrhea affects approximately 23% of users at the maximum 15mg dose, according to data from the SURMOUNT clinical trials. This gastrointestinal side effect typically begins 2-3 days after your injection and peaks around week 5 during dose escalation. Diarrhea is the second most common GI side effect after nausea when taking this weight management [...]
How Zepbound Works: Dual GLP-1/GIP Action – Appetite Off Week 1
Zepbound activates GLP-1 and GIP receptors simultaneously-reducing appetite significantly within days, slowing gastric emptying by approximately 40%, and producing average weight loss of up to 21% by week 72. This dual hormone action is superior to single GLP-1 drugs like Wegovy and Ozempic. According to the FDA approval announcement, Zepbound (tirzepatide) represents a breakthrough in [...]
Zepbound Dose Schedule: 2.5mg Start → 15mg Max + Maintenance Guide
The Zepbound dose schedule follows FDA-approved titration starting at 2.5mg once weekly, increasing every 4 weeks to reach the maximum recommended dosage of 15mg. According to FDA prescribing information, this slow titration approach reduces gastrointestinal adverse reactions while allowing your body to adjust to this injectable prescription medicine. In clinical trials like SURMOUNT-1, adults taking [...]
Zepbound Injection Sites: Abdomen, Thigh, Arm + Needle Size Guide
The Zepbound auto-injector delivers precise doses ranging from 2.5mg to 15mg in approximately 10 seconds. According to the FDA prescribing information, the approved injection sites for Zepbound are the stomach (maintaining at least 2 inches from the navel), outer thigh, and back of the upper arm. The Zepbound pen comes with a pre-attached 32-gauge, 4mm [...]
